<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04110665</url>
  </required_header>
  <id_info>
    <org_study_id>AOI 2017-1316-47</org_study_id>
    <nct_id>NCT04110665</nct_id>
  </id_info>
  <brief_title>Multimodal Analgesia Strategies After Major Shoulder Ambulatory Surgery</brief_title>
  <acronym>Shoulder1</acronym>
  <official_title>Evaluation of Multimodal Oral Strategies Using Sequential Analysis (Tramadol, Opioid) After Shoulder Ambulatory Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nīmes</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nīmes</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the addition of tramadol, or nefopam or opioid to paracetamol and
      ketoprofene in the treatment of pain in adults after shoulder ambulatory surgery. In a first
      step, 30 patients will receive tramadol as rescue analgesia in combination with paracetamol
      and ketoprofene, while the other will receive nefopam or opioid in a sequential analysis that
      will be performed every 20 patients using the QoR 40 survey.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Multimodal analgesia using acetaminophen with non steroidal anti inflammatory is commonly
      used for pain relief after ambulatory surgery. Tramadol achieves pain relief when rescue
      analgesia is needed after this surgery, but induces side effects (nausea, vomiting,
      discomfort, sleep disorder...). Other drugs could be used to reduce the side effects of
      tramadol and improve postoperative experience : nefopam or opioid (immediate or delayed
      release medication). Using a survey that describes pain, comfort, emotion or physical status
      (QoR 40), the investigators analyse the impact of various multimodal strategies using
      tramadol or nefopam or opioid that is necessary to improve postoperative experience.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2017</start_date>
  <completion_date type="Anticipated">December 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <intervention_model_description>Evaluation of the treatment based on QoR40 survey every 20 patients</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quality of Recovery (QoR) 40 survey</measure>
    <time_frame>Day 2</time_frame>
    <description>score based on 200 points (minimum 40, maximum 200), 40 questions (5 points for each question)</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Tendon Injuries</condition>
  <arm_group>
    <arm_group_label>Paracetamol+ ketoprofene and Tramadol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Paracetamol per os 1g every 6 hours and ketoprofene 100 mg per os every 12 hours were systematically administered. Tramadol 100 mg per os every 6 hours was added when pain was &gt; 3/10 on a numeric ranking scale (0 no pain, 10 worst pain).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Paracetamol+ ketoprofene+ Nefopam and Tramadol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Paracetamol per os 1g every 6 hours and ketoprofene 100 mg per os every 12 hours and Nefopam 120 mg intravenously were systematically administered. Tramadol 100 mg per os every 6 hours was added when pain was &gt; 3/10 on a numeric ranking scale (0 no pain, 10 worst pain).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Paracetamol+ ketoprofene and morphine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Paracetamol per os 1g every 6 hours and ketoprofene 100 mg per os every 12 hours were systematically administered. Opioid immediate release (morphine 10 mg) per os every 6 hours was added when pain was &gt; 3/10 on a numeric ranking scale (0 no pain, 10 worst pain).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Paracetamol+ ketoprofene+Opioid delayed release and morphine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Paracetamol per os 1g every 6 hours and ketoprofene 100 mg per os every 12 hours and 20 mg of opioid delayed release (Oxycodone) were systematically administered. Opioid immediate release (morphine 10 mg) per os every 6 hours was added when pain was &gt; 3/10 on a numeric ranking scale (0 no pain, 10 worst pain).</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tramadol</intervention_name>
    <description>Tramadol 100 mg tablet</description>
    <arm_group_label>Paracetamol+ ketoprofene and Tramadol</arm_group_label>
    <arm_group_label>Paracetamol+ ketoprofene+ Nefopam and Tramadol</arm_group_label>
    <other_name>Paracetamol</other_name>
    <other_name>Ketoprofene</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nefopam 20 MG/ML</intervention_name>
    <description>120 mg for 24 hours</description>
    <arm_group_label>Paracetamol+ ketoprofene+ Nefopam and Tramadol</arm_group_label>
    <other_name>Paracetamol</other_name>
    <other_name>Ketoprofene</other_name>
    <other_name>Tramadol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine Sulfate</intervention_name>
    <description>Tablet 10mg</description>
    <arm_group_label>Paracetamol+ ketoprofene and morphine</arm_group_label>
    <arm_group_label>Paracetamol+ ketoprofene+Opioid delayed release and morphine</arm_group_label>
    <other_name>Paracetamol</other_name>
    <other_name>Ketoprofene</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oxycodone 20mg</intervention_name>
    <description>release</description>
    <arm_group_label>Paracetamol+ ketoprofene+Opioid delayed release and morphine</arm_group_label>
    <other_name>Paracetamol</other_name>
    <other_name>Ketoprofene</other_name>
    <other_name>Morphine Sulfate</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  shoulder surgery

          -  under general anesthesia with an nterscalenic block

          -  written informed consent

          -  age &gt; 18 years

        Exclusion Criteria:

          -  age &lt; 18years

          -  emergency surgery

          -  refusal

          -  drug or opioid abuses
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>benjamin Garnaud, MD</last_name>
    <role>Study Director</role>
    <affiliation>CHU Nimes, Nimes University, France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>philippe cuvillon, PhD, MD</last_name>
    <phone>33-1-4 66 68 30 50</phone>
    <email>philippe.cuvillon@chu-nimes.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>christophe masseguin</last_name>
    <phone>33-1-4 66 68 30 50</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU de Nimes</name>
      <address>
        <city>Nîmes</city>
        <zip>30029</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anissa Megzari</last_name>
      <phone>04.66.68.42.36</phone>
      <email>drc@chu-nimes.fr</email>
    </contact>
    <investigator>
      <last_name>Philippe Cuvillon</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christophe Boisson</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gautier Buzancais</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean-Yves Lefrant</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>September 10, 2019</study_first_submitted>
  <study_first_submitted_qc>September 30, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 1, 2019</study_first_posted>
  <last_update_submitted>September 30, 2019</last_update_submitted>
  <last_update_submitted_qc>September 30, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 1, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centre Hospitalier Universitaire de Nīmes</investigator_affiliation>
    <investigator_full_name>Philippe Cuvillon</investigator_full_name>
    <investigator_title>Clinical Professor, Head of Anesthesia department</investigator_title>
  </responsible_party>
  <keyword>shoulder</keyword>
  <keyword>surgery</keyword>
  <keyword>analgesia</keyword>
  <keyword>opioid</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tendon Injuries</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Oxycodone</mesh_term>
    <mesh_term>Tramadol</mesh_term>
    <mesh_term>Nefopam</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>2021</ipd_time_frame>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

